Clinical Trial Update: Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 randomized, double-blind, placebo-controlled study to evaluate the effect of roflumilast on endothelial function …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: Spanish Research Center for Respiratory Diseases | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: UNKNOWN